Exclusive special offer and discount title banner vector image

FRANCE BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

France Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers)


MARKET OVERVIEW

The France biopsy devices market is predicted to grow at a CAGR of 8.01% over the forecast period of 2024-2032 and is set to reach a revenue of $xx million by 2032

The biopsy devices market in France is substantively advancing, influenced by the surge in healthcare expenditure. As France allocates more resources to healthcare, there is an increased capacity for investment in advanced medical technologies, including biopsy devices. This financial commitment enhances the accessibility and affordability of modern biopsy technologies, contributing to improved diagnostic capabilities across the country.

The market is also witnessing a preeminent shift towards preventive healthcare. With an increasing emphasis on early detection and disease prevention, biopsy devices play a crucial role in screening and identifying potential health issues before they progress. This proactive approach aligns with broader healthcare initiatives in France aimed at reducing the burden of diseases through preventive measures, further driving the demand for advanced biopsy technologies.

France Biopsy Devices Market

To Know More About This Report, Request a Free Sample Copy

Additionally, advancements in biopsy technology are another pivotal driver of the market. Ongoing research and development efforts have led to innovative biopsy techniques, such as minimally invasive procedures and the integration of artificial intelligence in pathology. These technological advancements not only enhance the accuracy of diagnoses but also contribute to patient comfort and quicker recovery times, reinforcing the adoption of biopsy devices across healthcare facilities in France. Therefore, these factors are set to propel the market’s growth in France over the forecast period.

The France biopsy devices market segmentation includes product, application, and end use. The application segment incorporates oncology, gastroenterology, pulmonology, dermatology, and other applications. With cancer being a leading cause of morbidity and mortality in France, biopsy devices are important in diagnosing and staging various cancers. These devices aid oncologists in obtaining tissue samples for precise analysis, enabling accurate cancer diagnoses and facilitating personalized treatment plans. The continuous evolution of biopsy technologies enhances their effectiveness in oncology, offering clinicians valuable tools for early detection and improved management of cancer patients across the healthcare spectrum in France.

Another key application in the France biopsy devices market is gastroenterology. The utilization of biopsy devices in gastroenterology is instrumental in diagnosing and monitoring conditions affecting the digestive system. Biopsy procedures help gastroenterologists obtain tissue samples from the gastrointestinal tract, aiding in the identification of disorders such as inflammatory bowel disease, celiac disease, and gastrointestinal cancers. 

The advancements in minimally invasive biopsy techniques contribute to patient comfort and faster recovery times in gastroenterological procedures. This application segment underscores the versatility of biopsy devices, demonstrating their significance in addressing diagnostic challenges across diverse medical specialties, ultimately contributing to enhanced patient care and treatment outcomes in the field of gastroenterology within the market.

Some of the leading players in the France biopsy devices market are Conmed Corporation, Cardinal Health, Boston Scientific, etc. 

Boston Scientific, a prominent global medical technology company with its headquarters in Marlborough, Massachusetts, specializes in the development and manufacturing of medical devices. The company has a notable presence in Voisins-le-Bretonneux, France, where it is recognized for its dedication to innovation, offering advanced solutions aimed at improving patient outcomes and enhancing healthcare procedures.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million) 
Segments Analyzed
Product, Application, and End Use
Countries AnalyzedFrance
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, Conmed Corporation, Boston Scientific, Becton Dickinson and Company
TABLE OF CONTENTS 
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    6. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR FRANCE
    4. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE- BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. BOSTON SCIENTIFIC
      6. BECTON DICKINSON AND COMPANY

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: FRANCE BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: FRANCE BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: FRANCE BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: FRANCE BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: KEY PLAYERS OPERATING IN FRANCE BIOPSY DEVICES MARKET

TABLE 11: LIST OF MERGERS & ACQUISITIONS

TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR FRANCE

FIGURE 4: VALUE CHAIN ANALYSIS

FIGURE 5: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 6: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 7: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 8: FRANCE BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 9: FRANCE BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: FRANCE BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 11: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 12: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 13: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 14: FRANCE BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 15: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 16: FRANCE BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 17: FRANCE BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 18: FRANCE BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: FRANCE BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 20: FRANCE BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 21: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023

FIGURE 22: FRANCE BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 23: FRANCE BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 24: FRANCE BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FAQ’s